Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 19151-19160 Newer>

The Motley Fool December 14, 2006 Rich Smith	Dueling Fools: Apple Bear Rebuttal Apple's not a terrible company to invest in -- it's just priced too high.
The Motley Fool December 14, 2006 Alyce Lomax	Dueling Fools: Apple Bull Rebuttal Value investors can scoff if they like, but those looking for growth know Apple's got it.
The Motley Fool December 14, 2006 Anders Bylund	Ciena Paints a Pretty Picture: Fool by Numbers The networking equipment maker released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool December 14, 2006 Alyce Lomax	Dueling Fools: Apple Bull Apple's recipe for success continues to entice investors.
The Motley Fool December 14, 2006 Rich Smith	Dueling Fools: Apple Bear Unless it does grow at 20%, Apple is overpriced.
The Motley Fool December 14, 2006 Shruti Basavaraj	Tiffany and Blue Nile's Clash of the Titans: A Recap A fight between old school and new school retailers. Which one comes out on top? Investors, take note.
The Motley Fool December 14, 2006 Brian Lawler	Celgene Faces a Generic Challenge An abbreviated application is only an opening salvo in Barr's challenge to Celgene's Thalomid patents. Investors, take note.
The Motley Fool December 14, 2006 Steven Mallas	NBC Broadcasting Good Times GE is predicting better times for its NBC Universal segment. Investors should nevertheless contain their enthusiasm on the outlook for NBC Universal.
The Motley Fool December 14, 2006 Seth Jayson	Don't Get Burned by Buzz It's natural to want to invest based on what the headlines are shouting at us, but history shows that investors are usually late to the game by the time the buzz is loudest.
The Motley Fool December 14, 2006 Brian Lawler	Vertex: Coming Together Nicely If telaprevir continues to show anything like the 80%-90% rate of undetectable hepatitis C virus at end of its trials, Vertex shareholders won't be dealing with too many more down days.
<Older 19151-19160 Newer> Return to current articles.